[LATEST STUDY] Is Pfizer vaccine actually not ‘effective’ for obese people?
The latest research studied the antibody response of two doses of the Pfizer vaccine in 247 healthcare workers.
Recently, Italian researchers carried out new research which showed frightening data for obese people. According to the latest data, the Pfizer vaccine has proven to be less effective in obese people.
The latest research studied the antibody response of two doses of the Pfizer vaccine in 247 healthcare workers. The research concluded that obese healthcare workers produced only half the required antibodies (when injected with the vaccine) in comparison to healthy people.
Although the study has not yet been peer-reviewed, it provides the first direct evidence to suggest that a similar problem might occur with other Covid-19 vaccines.
The groundbreaking research highlighted the challenges of vaccinating and protecting an obese population against the deadly Covid-19 virus, especially when the world is already grappling with the effects of the virus’s second wave.
The new findings can also be attributed to the pre-existing medical conditions that obese people already have, for instance, heart disease or type 2 diabetes.
Reports of the study read:
Since obesity is a major risk factor for morbidity and mortality for patients with Covid-19, it is mandatory to plan an efficient vaccination program in this subgroup.
It further stated:
Although further studies are needed, this data may have important implications for developing vaccination strategies for Covid-19, particularly in obese people.
What are your thoughts on this? Please share with us in the comment section below.